Drug war: Trump takes on big pharma
The Intelligence from The Economist
00:00
Challenges in Pharmaceutical Pricing and Innovation
This chapter examines recent government actions affecting the pharmaceutical industry, notably a Trump executive order aimed at reducing drug prices. It discusses the potential unintended consequences of such policies on drug development, supply chains, and manufacturing dynamics. The complex interplay between international pricing, tariffs, and the role of the U.S. market in pharmaceutical profitability is highlighted amidst ongoing scrutiny of Big Pharma.
Transcript
Play full episode
